Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Keryx Biopharmaceuticals

In Seth Klarman's portfolio · Baupost Group

Ticker KERX

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q4 2018 Sell 0  
Q3 2018 No change 25,791,678 0.7% $3.40 $87.7M
Q2 2018 No change 25,791,678 0.8% $3.76 $97.0M
Q1 2018 No change 25,791,678 1.0% $4.09 $105.5M
Q4 2017 No change 25,791,678 1.2% $4.65 $119.9M
Q3 2017 No change 25,791,678 2.3% $7.10 $183.1M
Q2 2017 No change 25,791,678 2.1% $7.23 $186.5M
Q1 2017 No change 25,791,678 1.9% $6.16 $158.9M
Q4 2016 No change 25,791,678 2.0% $5.86 $151.1M
Q3 2016 No change 25,791,678 1.9% $5.31 $137.0M
Q2 2016 No change 25,791,678 2.3% $6.62 $170.7M
Q1 2016 No change 25,791,678 1.7% $4.67 $120.4M
Q4 2015 No change 25,791,678 2.4% $5.05 $130.2M
Q3 2015 No change 25,791,678 1.4% $3.28 $84.5M
Q2 2015 Add 15% 25,791,678 4.3% $9.98 $257.4M
Q1 2015 Add 22% 22,380,200 4.8% $12.73 $284.9M
Q4 2014 No change 18,300,000 5.1% $14.15 $258.9M
Q3 2014 Add 74% 18,300,000 4.4% $13.75 $251.6M
Q2 2014 Add 67% 10,539,986 2.6% $15.38 $162.1M
Q1 2014 Buy 6,310,850 2.6% $17.04 $107.5M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.